Categories Earnings, Other Industries

Corning (NYSE: GLW): Q4 2019 Earnings Snapshot

— Corning Incorporated (NYSE: GLW) reported its fourth-quarter 2019 core earnings of $0.46 per share versus $0.44 per share expected.

— Net sales declined by 7% to $2.82 billion versus $2.70 billion expected.

Corning (GLW) Q4 2019 Earnings Snapshot

— Display Technologies sales dropped by 12% due to a decline in display glass volume and prices. Optical Communications sales fell by 23% due to lower volume and reduced production to decrease inventory.

— Environmental Technologies sales jumped by 17%. Specialty Materials sales increased by 14%. Life Sciences sales rose by 8% backed by the strength of new products for cell culture and gene therapy.

— In 2020, the company expects continued growth in Specialty Materials, Environmental Technologies, and Life Sciences.

— The company expects to return to sales and profit growth and expand margins in the second half of 2020 as the volume in Display Technologies and Optical Communications improves.

— Corning expects to add an incremental $3-4 billion in annual sales and improve profitability by the end of 2023 for delivering its strategy and growth framework goals.

— Through 2023, Corning expects to deliver 6-8% compound annual sales growth and 12-15% compound annual EPS growth while investing $10-12 billion in RD&E, capital and mergers, and acquisitions.

— Through 2023, the company plans to expand operating margin and ROIC, and deliver $8-10 billion to shareholders, including annual dividend per share increase of at least 10%.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top